Be'er-Sheva Mental Health Center, Ben-Gurion University of the Negev, P.O. Box 4600, Be'er-Sheva, 84170, Israel.
Curr Psychiatry Rep. 2011 Aug;13(4):295-304. doi: 10.1007/s11920-011-0202-6.
Abnormal involuntary dyskinetic movements in schizophrenia patients have been documented for more than 140 years. Clinicians should distinguish between two kinds of disturbances-spontaneous dyskinetic movements and movements induced by psychotropic medications-which may look familiar clinically. As a modern term, tardive dyskinesia (TD) is a potentially permanent neurological hyperkinetic movement disorder that occurs after months or years of taking psychotropic drugs. Several distinct forms of TD exist, specifically tardive akathisia, tardive blepharospasm, tardive dystonia, tardive gait, tardive myoclonus, tardive tremor, and tardive tics, and they have different pathophysiologies and treatment. The pathogenesis of TD remains unclear, and the pathophysiology is complex and multifactorial. Moreover, there is solid evidence of a genetic predisposition to TD. This article summarizes recent relevant publications concerning TD and the most recent studies regarding treatment of this disorder with antioxidative agents.
精神分裂症患者的异常不自主运动已有 140 多年的记载。临床医生应区分两种干扰-自发性运动障碍和精神药物引起的运动障碍-这在临床上可能看起来很熟悉。作为一个现代术语,迟发性运动障碍(TD)是一种潜在的永久性神经运动障碍,在服用精神药物数月或数年后发生。存在几种不同形式的 TD,具体包括迟发性静坐不能、迟发性眼睑痉挛、迟发性肌张力障碍、迟发性步态、迟发性肌阵挛、迟发性震颤和迟发性抽搐,它们具有不同的病理生理学和治疗方法。TD 的发病机制仍不清楚,其病理生理学复杂且多因素。此外,有确凿的证据表明 TD 存在遗传易感性。本文总结了最近有关 TD 的相关出版物以及关于用抗氧化剂治疗这种疾病的最新研究。